Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelets as immunogens.

A H Waters1

  • 1Department of Haematology, St Bartholomew's Hospital, Medical College, West Smithfield, London, UK.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third European Symposium on Platelet and Granulocyte Immunobiology June 27-29 1994, Cambridge, UK.

Platelets·2010
Same author

Psychological attributes of South African Navy Underwater Sabotage Device Disposal operators.

Military medicine·2002
Same author

Personality characteristics of South African navy divers.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2001
Same author

Personality characteristics of South African Navy submarine personnel.

Military medicine·2000
Same author

Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT.

British journal of haematology·1998
Same author

Management of alloimmunized, refractory patients in need of platelet transfusions.

Vox sanguinis·1997
Same journal

Pampiniform venous plexus thrombosis in a 37 years-old male patient with severe thrombocytosis: a multifactorial aetiology.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

PROS1 Cys475Tyr mutation associated with a type III protein S deficiency pattern.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Dynamic microclot profiling: thromboelastography advances precision management in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Genetic characterization of Glanzmann thrombasthenia: insights from novel igta2b mutations in a Tunisian patient cohort.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

Uterine fibroids as an underrecognized risk factor for venous thromboembolism: a narrative review.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same journal

SEER sonorheometry enhances fibrinolysis detection during liver transplantation with heparin.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
See all related articles

Immune responses to human platelet antigens (HPA) are rare, with human leucocyte antigen (HLA) class II restriction playing a key role. Autoimmune thrombocytopenia is more common, targeting glycoproteins IIb/IIIa and Ib/IX.

Area of Science:

  • Immunology
  • Hematology
  • Transfusion Medicine

Background:

  • Immune responses to human platelet antigens (HPA) are uncommon, unlike more frequent autoimmune thrombocytopenias.
  • Human leucocyte antigen (HLA) class II restriction is increasingly recognized as important in HPA alloimmunization.
  • Platelets express HLA class I antigens; primary HLA alloimmunization is typically due to contaminating leukocytes in transfusions.

Purpose of the Study:

  • To review the role of HLA class II restriction in immune responses to HPA.
  • To differentiate alloimmune from autoimmune thrombocytopenic conditions.
  • To re-examine mechanisms of drug-induced immune thrombocytopenia.

Main Methods:

  • Literature review focusing on immune responses to platelet antigens.

Related Experiment Videos

  • Analysis of evidence for HLA class II restriction in HPA alloimmunization.
  • Examination of antibody-target cell interactions in drug-induced thrombocytopenia.

    • Main Results:

    • Evidence supports HLA class II restriction in HPA alloimmunization, though it's not the rule.
    • Autoimmune thrombocytopenia is more prevalent than alloimmune types.
    • Key autoantigens include glycoproteins (Gp) IIb/IIIa and Ib/IX.
    • Re-evaluation of drug-induced immune thrombocytopenia mechanisms is ongoing.

    Conclusions:

    • HLA class II restriction is a significant factor in HPA alloimmunization.
    • Understanding the distinction between alloimmune and autoimmune thrombocytopenia is crucial.
    • Further research is needed to fully elucidate drug-induced immune thrombocytopenia mechanisms.